ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,426, issued on Oct. 6, was assigned to The Trustees of the University of Pennsylvania (Philadelphia).

"High throughput assays for detecting translation readthrough inducers" was invented by Barry S. Cooperman (Philadelphia) and Mikel D. Ghelfi (Philadelphia).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are systems and methods for high throughput screening to detect translation readthrough induced drugs (TRID). The systems use highly purified, eukaryotic cell-free protein synthesis systems that distinguish TRIDs acting directly on the protein synthesis machinery from those that act indirectly."

The patent was filed on Aug. 19, 2022, under ...